Go to the Globe and Mail homepage

Jump to main navigationJump to main content

(iStockPhoto)
(iStockPhoto)

Valeant buys minority stake in Brazilian company Add to ...

Valeant Pharmaceuticals International Inc. said it acquired a 19.9-per-cent stake in a Brazilian research company which is focused on tissue regeneration, for less than $10-million.

The Canadian drug maker has been increasing revenue, mostly through acquisitions, since Biovail Corp., Canada’s largest publicly owned pharmaceutical company, took over U.S.-based Valeant and assumed the Valeant name in September, 2010.

More related to this story

Valeant said it will have representation on Sao Paulo, Brazil-based Pele Nova Biotecnologia SA’s board.

Pele Nova produces active ingredients and skin products.

Follow us on Twitter: @GlobeInvestor

 
Live Discussion of VRX on StockTwits
More Discussion on VRX-T

More related to this story

Topics:

In the know

Most popular video »

Highlights

More from The Globe and Mail

Most Popular Stories